Title : 90Y-DOTA-Nimotuzumab: Synthesis of a Promising β- Radiopharmaceutical.

Pub. Date : 2022

PMID : 33397277






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study aimed to label the conjugate DOTA-nimotuzumab with yttrium-90, in order to provide a beta- emitting radioimmunoconjugate (90Y-DOTA-nimotuzumab) potentially useful to assess the feasibility of a new radio-guided surgery approach. Yttrium-90 amyloid beta precursor protein Homo sapiens